Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Eur Rev Med Pharmacol Sci ; 26(20): 7580-7593, 2022 10.
Artículo en Inglés | MEDLINE | ID: mdl-36314330

RESUMEN

OBJECTIVE: Polymerase ε exonuclease (POLE) is an enzyme involved in DNA replication and may be an attractive therapeutic target in various cancers. Here we sought to model the impact of specific POLE mutations on protein function. Due to the lack of a crystal structure, the tertiary structures of the wild type and four common mutants were modeled using I-Tasser server. MATERIALS AND METHODS: Molecular docking and dynamic simulation studies were performed, and the structure and function of the mutants analyzed through residue conservation analysis and protein folding energy changes. RESULTS: All mutants of POLE gene had favorable binding affinities compared with their wild type of counterpart. The P286R variant, but not the other variants, disrupted cladribine binding to the protein. Similarly, dynamics studies revealed instability of the P286R mutant, while V411L, L424V, and L424F appeared to favor cladribine binding. CONCLUSIONS: Since P286R is a hotspot mutation in endometrioid carcinomas, patients with this variant may not respond to cladribine. Population-based pharmacogenomics studies will be required to validate our results.


Asunto(s)
Carcinoma Endometrioide , ADN Polimerasa II , Femenino , Humanos , ADN Polimerasa II/química , ADN Polimerasa II/genética , ADN Polimerasa II/metabolismo , Cladribina/uso terapéutico , Exonucleasas/genética , Simulación del Acoplamiento Molecular , Mutación
2.
Clin Exp Dermatol ; 46(4): 704-709, 2021 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-33289110

RESUMEN

Aicardi-Goutières syndrome type 6 (AGS6) and dyschromatosis symmetrica hereditaria (DSH) are allelic disorders caused respectively by biallelic and heterozygous pathogenic variants in ADAR1. We report three unrelated children presenting with features of both AGS6 and DSH, two of whom had compound heterozygous pathogenic variants in ADAR1. We also describe the novel genetic variants in our cases and review the literature on association of ADAR1-related AGS6 and DSH with these phenotypes.


Asunto(s)
Adenosina Desaminasa/genética , Enfermedades Autoinmunes del Sistema Nervioso/genética , Heterocigoto , Mutación , Malformaciones del Sistema Nervioso/genética , Trastornos de la Pigmentación/congénito , Proteínas de Unión al ARN/genética , Enfermedades Autoinmunes del Sistema Nervioso/complicaciones , Encéfalo/diagnóstico por imagen , Encéfalo/patología , Preescolar , Humanos , India , Lactante , Imagen por Resonancia Magnética , Malformaciones del Sistema Nervioso/complicaciones , Fenotipo , Trastornos de la Pigmentación/complicaciones , Trastornos de la Pigmentación/genética
3.
Physiol Res ; 65(5): 871-878, 2016 11 23.
Artículo en Inglés | MEDLINE | ID: mdl-27429110

RESUMEN

The goal of this study was to identify small molecular weight compounds that bind to sclerostin using in-silico methods because of the established importance of sclerostin-based therapies for the treatment of disease characterized by low bone mass. The zinc database (Zdb) revealed that nine potential molecules bind to the loop2 region (functional site) of sclerostin with ADME/T properties that are within an acceptable range defined for human use. Compounds 30160056 and 56871042 showed the highest docking score. Density functional theory (by HOMO, LUMO and MESP analysis) and MM/GBSA analysis showed that four compounds 30160056, 56871042, 72112226 and 43920281 exhibit high stability among the nine small molecules identified. Induced Docking Fit and Pymol software analyses revealed that the identified compounds differ in the interaction with amino acids in the loop2 region of sclerostin. Six compound exhibited interaction with Ile95 and 2 compounds with Asn93, an amino acid in the loop2 region known to be involved in sclerostin's inhibitory effect, suggesting that the identified compounds have the potential to bind and neutralize sclerostin function. Furthermore, compound 43920281 showed a low risk of toxicity and drug-like characteristic features compared to all nine identified compounds. In conclusion, in silico analysis identified a novel compound 43920281 as a potent anti-sclerostin therapeutic for drug development for the treatment of osteoporosis.


Asunto(s)
Proteínas Morfogenéticas Óseas/metabolismo , Simulación del Acoplamiento Molecular , Osteoporosis/metabolismo , Proteínas Adaptadoras Transductoras de Señales , Simulación por Computador , Marcadores Genéticos
4.
Genet Mol Res ; 11(3): 2939-45, 2012 Aug 29.
Artículo en Inglés | MEDLINE | ID: mdl-22782629

RESUMEN

Studies of genetic mutations that have been used in predicting glioma prognosis have revealed a complex relationship between clinical and genetic factors. Epidermal growth factor (EGF) and the NAT2 gene play a central role in carcinogenesis. An adenine (A) to guanine (G) single nucleotide polymorphism at position 61 in the 5'-untranslated region (5'-UTR) of the EGF gene has been found to be associated with levels of EGF production, and the mutations in the NAT2 gene have been postulated as a risk factor for cancer. We investigated EGF and the NAT2 gene in 13 glioma tissue samples and 12 normal controls. In the EGF 5'-UTR 61G polymorphism, the heterozygote GA was the most common genotype in the glioma patients. In the NAT2 polymorphism at nucleotide position 857G/A, the G allele and the GG genotype were the most prevalent forms in both the glioma and normal samples. We did not find any homozygous AA genotypes in the glioma patients. Based on this preliminary evidence, the EGF 5'-UTR at position 61 and the NAT2 SNP at position 857 polymorphisms are associated with increased risk for glioma.


Asunto(s)
Regiones no Traducidas 5'/genética , Arilamina N-Acetiltransferasa/genética , Neoplasias Encefálicas/genética , Factor de Crecimiento Epidérmico/genética , Predisposición Genética a la Enfermedad , Glioma/genética , Polimorfismo de Nucleótido Simple/genética , Alelos , Neoplasias Encefálicas/enzimología , Estudios de Casos y Controles , Electroforesis en Gel de Agar , Frecuencia de los Genes/genética , Estudios de Asociación Genética , Glioma/enzimología , Humanos , Malasia , Nucleótidos/genética , Reacción en Cadena de la Polimerasa , Polimorfismo de Longitud del Fragmento de Restricción
5.
J Clin Neurosci ; 19(4): 574-7, 2012 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-22305869

RESUMEN

In neurosurgery and ear, nose and throat surgery the application of computerised navigation systems for guiding operations has been expanding rapidly. However, suitable models to train surgeons in using navigation systems are not yet available. We have developed a technique using an industrial, rapid prototyping process from which accurate spatial models of the cranium, its contents and pathology can be reproduced for teaching. We were able to register, validate and navigate using these models with common available navigation systems such as the Medtronic StealthStation S7®.


Asunto(s)
Modelos Anatómicos , Neuronavegación/educación , Cráneo/anatomía & histología , Cráneo/cirugía , Humanos
6.
Indian J Pharm Sci ; 74(2): 141-51, 2012 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-23325995

RESUMEN

Phosphoinositide-dependent kinase-1 plays a vital role in the PI3-kinase signaling pathway that regulates gene expression, cell cycle growth and proliferation. The common human cancers include lung, breast, blood and prostate possess over stimulation of the phosphoinositide-dependent kinase-1 signaling and making phosphoinositide-dependent kinase-1 an interesting therapeutic target in oncology. A ligand-based pharmacophore and atom-based 3D-QSAR studies were carried out on a set of 82 inhibitors of PDK1. A six point pharmacophore with two hydrogen bond acceptors (A), three hydrogen bond donors (D) and one hydrophobic group (H) was obtained. The pharmacophore hypothesis yielded a 3D-QSAR model with good partial least square statistics results. The training set correlation is characterized by partial least square factors (R(2) = 0.9557, SD = 0.2334, F = 215.5, P = 1.407e-32). The test set correlation is characterized by partial least square factors (Q(2) ext = 0.7510, RMSE = 0.5225, Pearson-R =0.8676). The external validation indicated that our QSAR model possess high predictive power with good value of 0.99 and value of 0.88. The docking results show the binding orientations of these inhibitors at active site amino acid residues (Ala162, Thr222, Glu209 and Glu166) of phosphoinositide-dependent kinase-1 protein. The binding free energy interactions of protein-ligand complex have been calculated, which plays an important role in molecular recognition and drug design approach.

7.
J Cytol ; 29(4): 270-2, 2012 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-23326036

RESUMEN

Osteoclast-like giant cell tumor of the pancreas is a rare non-endocrine neoplasm composed of reactive multinucleated giant cells admixed with mononuclear stromal cells. We report a case of osteoclast-like giant cell tumor of the pancreas in a 58-year-old female with vague clinical symptoms. Endoscopic ultrasound-guided aspirate from the mass revealed numerous characteristic osteoclast-like giant cells.

8.
Br J Neurosurg ; 22 Suppl 1: S41-4, 2008.
Artículo en Inglés | MEDLINE | ID: mdl-19085352

RESUMEN

Deep brain stimulation (DBS) of the pedunculopontine nucleus (PPN) is a novel neurosurgical therapy developed to address symptoms of gait freezing and postural instability in Parkinson's disease and related disorders. Here, we summarize our non-human primate and neuroimaging research of relevance to our surgical targeting of the PPN. We also describe our clinical experience of PPN DBS with greatest motor improvements achieved by stimulation at low frequencies.


Asunto(s)
Estimulación Encefálica Profunda/métodos , Enfermedad de Parkinson/terapia , Núcleo Tegmental Pedunculopontino/cirugía , Animales , Imagen de Difusión por Resonancia Magnética , Primates
9.
Neuroimage ; 37(3): 694-705, 2007 Sep 01.
Artículo en Inglés | MEDLINE | ID: mdl-17644361

RESUMEN

Deep brain stimulation (DBS) of the subthalamic nucleus (STN) is the most common surgical therapy for Parkinson' s disease (PD). DBS of the pedunculopontine nucleus (PPN) is emerging as a promising surgical therapy for PD as well. In order to better characterize these nuclei in humans, we determined the anatomical connections of the PPN and STN and the topography of these connections using probabilistic diffusion tractography. Diffusion tractography was carried out in eight healthy adult subjects using diffusion data acquired at 1.5 T MRI (60 directions, b=1000 s/mm(2), 2 x 2 x 2 mm(3) voxels). The major connections that we identified from single seed voxels within STN or PPN were present in at least half the subjects and the topography of these connections within a 36-voxel region surrounding the initial seed voxel was then examined. Both the PPN and STN showed connections with the cortex, basal ganglia, cerebellum, and down the spinal cord, largely matching connections demonstrated in primates. The topography of motor and associative brain areas in the human STN was strikingly similar to that shown in animals. PPN Topography has not been extensively demonstrated in animals, but we showed significant topography of cortical and subcortical connections in the human PPN. In addition to demonstrating the usefulness of PDT in determining the connections and topography of small grey matter structures in vivo, these results allow for inference of optimal DBS target locations and add to our understanding of the role of these nuclei in PD.


Asunto(s)
Corteza Cerebral/anatomía & histología , Imagen de Difusión por Resonancia Magnética/métodos , Fibras Nerviosas Mielínicas/ultraestructura , Vías Nerviosas/anatomía & histología , Núcleo Tegmental Pedunculopontino/anatomía & histología , Núcleo Subtalámico/anatomía & histología , Adulto , Femenino , Humanos , Masculino
10.
J Clin Pathol ; 59(11): 1166-70, 2006 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-16556662

RESUMEN

BACKGROUND: The presence of lipid in the cell cytoplasm is useful for supporting the diagnosis of sebaceous gland carcinoma (SGC). Currently this requires histochemical stains that are carried out on frozen sections of unprocessed tissue. Recently, several anti-adipocytic antibodies that recognise proteins associated with lipid vesicles have been described. These antibodies can be applied to paraffin-wax sections. AIM: To assess the ability of anti-adipocytic antibodies to identify intracytoplasmic lipid in SGC. METHODS: Immunohistochemistry with a monoclonal antibody to adipophilin and polyclonal antibodies to perilipin and TIP47/PP17 was carried out on archival, formalin-fixed, paraffin-wax-embedded sections of 26 samples of SGC. The immunostaining was compared with 22 other eyelid tumours (11 basal cell carcinomas (BCC), 10 squamous cell carcinomas (SCC) and 1 Merkel cell tumour). RESULTS: Immunohistochemical staining was positive in 23, 10 and 2 cases of 26 SGC with adipophilin, perilipin and TIP47, respectively. The positive staining identified cytoplasmic lipid vesicles. Anti-adipophilin was positive in five other eyelid tumours (4 BCC and 1 SCC) staining small cytoplasmic granules that can be easily distinguished from the staining in SGC. CONCLUSIONS: Immunohistochemical staining for adipophilin and perilipin is a useful ancillary technique for the demonstration of lipid in SGC that may be applied to paraffin-wax sections.


Asunto(s)
Adenocarcinoma Sebáceo/diagnóstico , Biomarcadores de Tumor/análisis , Neoplasias de los Párpados/diagnóstico , Lípidos/análisis , Neoplasias de las Glándulas Sebáceas/diagnóstico , Adipocitos/inmunología , Anticuerpos Monoclonales/inmunología , Carcinoma Basocelular/diagnóstico , Carcinoma de Células Escamosas/diagnóstico , Proteínas Portadoras , Proteínas de Unión al ADN/análisis , Diagnóstico Diferencial , Humanos , Péptidos y Proteínas de Señalización Intracelular/análisis , Proteínas de la Membrana , Adhesión en Parafina , Péptidos/análisis , Perilipina-1 , Perilipina-2 , Perilipina-3 , Fosfoproteínas/análisis , Proteínas Gestacionales/análisis , Proteínas de Transporte Vesicular
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA